Fingolimod is largely used as multiple sclerosis treatment and acts on the sphingosine-1-phosphate receptor, inhibiting lymphocyte egress from lymph nodes and inhibiting their recirculation [138]. The gene discussed is S1PR1; the disease is multiple sclerosis.